Search
for
Sort by
Research 361–390 of 1000+
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Enzymatic Synthesis of α-Glucosyl-Baicalin through Transglucosylation via Cyclodextrin Glucanotransferase in Water
- Bioactive-Based Cosmeceuticals: An Update on Emerging Trends
- A novel microparticle based formulation for topical delivery of FOL-005, a small peptide
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Examination of epigenetic inhibitor zebularine in treatment of skin wounds in healthy and diabetic mice
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Molecular Targets in Modern Cosmetic Science
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Identification of Beta-Sitosterol and Stigmasterol as Possible Inhibitors of 5 Alpha-Reductase 1: An In-Silico Study
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Diabetes Mellitus Inhibits Hair Follicle Regeneration by Inducing Macrophage Reprogramming-Mediated Pyroptosis
- Hedgehog Pathway Inhibitors against Tumor Microenvironment